Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
ObesityOverweightMetabolic Diseases
Interventions
BEHAVIORAL

Low Calorie Diet (LCD)

A Diet History Questionnaire was completed and subjects had dietary counseling and were provided shakes. The low calorie diet began, to continued for a period of 8 weeks.

DRUG

Phentermine

"Individuals not on track to achieve their target weight by four weeks received the drug Phentermine to promote weight loss. Then, following eight weeks LCD (or four weeks LCD + four weeks LCD+Phentermine), in the event that they did not achieve the target weight loss, subjects were given the option to continue with the LCD + Phentermine for up to an additional 12 weeks, under a doctor's supervision.~Protection Against Risk:~* Prior to administering any phentermine, a history and physical including EKG will be conducted (at the screening visit) and will be used to determine whether the participant is clear to receive the medication.~* Participants will see the study doctor or nurse practitioner at every study visit after the drug is initiated."

Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

AdventHealth Translational Research Institute

OTHER